Biomaterials are being redesigned to control post-translational modification during repair
Post-translational modification sits at the center of cellular control. After proteins are synthesized, covalent changes such as phosphorylation, acetylation and ubiquitination can redirect where those proteins go, how active they are and which molecular partners they recruit. In regenerative medicine, that level of control is more than a biochemical curiosity; it is a route to influence the signaling programs that determine whether tissue heals with organized structure or stalls in a maladaptive state.
This review places post-translational modification at the center of biomaterial design for regeneration. The argument is straightforward: if tissue repair depends on tightly choreographed signaling, then materials that can shape that signaling may be able to push cells toward a more productive repair phenotype. The logic spans beyond one pathway or one tissue. It extends to the broader problem of how to translate local physicochemical cues into intracellular decisions that affect lineage commitment, migration, matrix remodeling and survival.
A single molecular switch can alter how a cell reads its environment.
Physicochemical cues from materials can be converted into intracellular signaling changes
Biomaterials bring a useful feature to the repair setting: their physicochemical properties can be engineered. Surface characteristics, bulk composition and reactive behavior can all be tuned, and those changes can be translated by cells into internal signaling events. In practice, this means a scaffold or matrix is not just a passive support. It can act as an instructive interface that influences protein modification patterns and, in turn, the downstream pathways that govern repair.
The review describes several ways biomaterials may regulate PTM. Intrinsic material properties can alter how cells perceive stiffness, topography and chemistry. Surface modifications can further refine that interface, shaping the immediate molecular environment at the cell-material boundary. A separate layer of control comes from reactive oxygen species regulation, which matters because oxidative stress can distort signaling networks and perturb PTM-dependent protein function. By managing ROS-related biology, biomaterials may help preserve the molecular conditions needed for coordinated regeneration.
This is where the biology becomes clinically relevant. Tissue repair fails when signals are excessive, mislocalized or incomplete. PTM control offers a way to intervene upstream of those failures, at the level where cells interpret stress and decide whether to proliferate, differentiate or enter a reparative program.
Bone repair, vascular healing, muscle recovery and neural regeneration all depend on signaling precision
The review organizes the field around several tissue systems, each of which places different demands on biomaterial design. Bone regeneration depends on the orchestration of osteogenic cues and matrix organization. Vascular repair requires endothelial compatibility and stable vessel formation. Muscle recovery depends on cellular activation and structural alignment. Neural regeneration raises the bar even higher, because axonal growth, guidance and synaptic integration all require exquisitely controlled molecular signaling.
Across these settings, biomaterial-mediated PTM regulation offers a common principle: local control of the molecular code that governs repair. In bone, this can support a microenvironment favorable to rebuilding organized tissue. In vascular applications, the same conceptual framework can help support the cellular events needed for vessel restoration. In muscle and neural tissue, PTM-sensitive design may help coordinate regeneration in systems where architecture and signaling are tightly interwoven.
These tissue examples are not interchangeable, but they do share a dependence on the same fundamental process. Cells do not respond to a material simply because it is present. They respond because the material alters the signals that proteins carry, the interactions those proteins form and the fate decisions that follow.
ROS regulation adds another layer to the therapeutic design problem
Oxidative stress is one of the most biologically disruptive features of injured tissue. Reactive oxygen species can amplify damage, distort molecular signaling and interfere with pathways that normally support repair. For that reason, materials designed to regulate ROS are not merely trying to limit injury. They are also attempting to preserve the signaling environment in which PTM can function normally.
That point matters because PTM is not static. It is dynamic, context dependent and sensitive to environmental stress. If ROS levels are poorly controlled, the protein modification landscape can shift in ways that weaken repair or push cells away from regenerative states. Biomaterials that reduce or modulate oxidative stress may therefore support regeneration indirectly by stabilizing the conditions under which PTM operates.
The therapeutic promise here is elegant but demanding. It asks materials to do more than provide structure. They must tune chemistry, control stress responses and influence intracellular signaling without introducing new biological noise.
Precision PTM control remains a design challenge, not a solved engineering problem
The review closes on the practical limitations that continue to shape this field. Current strategies still face major challenges in achieving precise PTM control across different tissues and biological contexts. A material that works in one setting may behave differently in another because the local injury environment, cell populations and signaling demands are not the same.
Bioengineering strategies will therefore need to become more adaptive. Future work will likely depend on integrating knowledge of protein chemistry, material science and tissue-specific biology into more refined platforms. The goal is not simply to create a scaffold that interacts with cells, but to create a system that can reliably steer the molecular events that determine whether repair is successful.
For now, the review frames PTM-regulating biomaterials as an emerging strategy for regeneration rather than a finished clinical technology. The concept is biologically compelling because it addresses repair at the level of intracellular decision-making. Its real test will be whether these engineered materials can produce consistent, tissue-specific control over the protein modification programs that govern healing.